Brian S. Tyler is the CEO of McKesson Corporation (NYSE: MCK), the largest pharmaceutical distributor in North America and one of the biggest companies in the world by revenue. Appointed CEO on April 1, 2019, Tyler succeeded John Hammergren after spending more than 25 years rising through McKesson’s leadership ranks. Under his stewardship, McKesson delivered fiscal year 2025 revenues of $359.1 billion, securing a consistent top-10 position on the Fortune 500. With a market capitalization exceeding $121 billion as of early 2026, McKesson distributes approximately one-third of all pharmaceuticals consumed in North America.
(Suggested: UnitedHealth Group CEO Email & Net Worth)

Brian Tyler — Quick Facts
McKesson Competitors
McKesson operates in the highly concentrated pharmaceutical distribution industry. Together with its two main rivals, McKesson controls over 90% of the U.S. pharmaceutical distribution market. Key competitors include:
- Cencora (formerly AmerisourceBergen) — McKesson’s most direct rival with $294B+ in annual revenue
- Cardinal Health — The third member of the pharmaceutical distribution oligopoly
- Owens & Minor — Competes in medical-surgical distribution
- Henry Schein — Healthcare products distribution
- Medline Industries — Major player in medical-surgical supplies
- CVS Health — Retail pharmacy and healthcare services
- Walgreens Boots Alliance — Pharmacy-led healthcare company
Brian Tyler Net Worth 2026 — McKesson CEO Salary
As of 2026, Brian Tyler’s net worth is estimated at approximately $50-100 million, based on his cumulative compensation over more than seven years as CEO, SEC-disclosed stock holdings, and long-term equity awards. According to insider trading filings, Tyler directly owns approximately 4,227 shares of McKesson (MCK) stock worth over $3.59 million, though this represents only his direct holdings and does not include previously vested and sold equity awards.
Over the past 18 months, Tyler has made 11 insider transactions in McKesson stock, with a net sale of 109,705 shares — a common practice among Fortune 500 executives for diversification and tax planning.
McKesson CEO Compensation Breakdown (FY2025)
McKesson Net Worth 2026 — Is McKesson Profitable?
Yes, McKesson is a highly profitable company and one of the largest in the world by revenue. Under CEO Brian Tyler, McKesson has delivered consistent growth across all key financial metrics.
McKesson Financial Summary (FY2025 vs FY2024)
(Recommended: UnitedHealth Group CEO Email & Net Worth)
McKesson CEO Email Address | Brian Tyler Contact
Below are the official contact details for McKesson CEO Brian Tyler:
Career & Education — Company, University, & College
Brian Tyler’s career has been defined by his deep commitment to McKesson, where he has spent more than 25 years. Before joining the company, Tyler applied his economics expertise in healthcare consulting. Below is his complete career timeline:
Brian Tyler Career Timeline
Brian Tyler joined McKesson in 1997 as vice president of strategy and business development for McKesson Distribution Solutions. Over the following two decades, he held leadership positions spanning virtually every major division of the company, including McKesson Europe, North American Pharmaceutical Distribution, Corporate Strategy, U.S. Pharmaceutical, Medical-Surgical Solutions, and McKesson Specialty Care Solutions.
His international experience was pivotal — as President and COO of McKesson Europe and Chairman of the Management Board of McKesson Europe AG from 2016 to 2018, Tyler gained a deep understanding of global pharmaceutical distribution markets. He was then promoted to President and Chief Operating Officer of the entire corporation in August 2018 before assuming the CEO role on April 1, 2019.
Before McKesson, Tyler spent approximately three years at Integral, Inc. in Cambridge, Massachusetts, as a senior associate in healthcare consulting, where he applied his doctoral economics training to healthcare industry challenges.
Education
Tyler earned his undergraduate degree in economics with high honors from the University of California, Santa Cruz in 1989. He then pursued graduate studies at the University of Chicago‘s Department of Economics — one of the most prestigious economics programs in the world — where he completed both his M.A. and Ph.D. His doctoral specializations included industrial organization, labor economics, and public finance/project evaluation. He studied under a grant from the National Science Foundation (NSF).

Brian Tyler Wiki — Age, Family, & More
McKesson CEO Brian Tyler (age 58) is based in the Irving, Texas area near McKesson’s corporate headquarters. Tyler keeps his personal and family life relatively private, though he is known to be a parent. He maintains a low public profile outside of his corporate responsibilities, focusing his energy on McKesson’s mission of improving healthcare delivery.
Board Memberships & Community Involvement
- Republic Services, Inc. — Board of Directors member since March 2021
- International Federation of Pharmaceutical Wholesalers (IFPW) — Board of Directors member
- American Cancer Society — Chair, North Texas chapter of CEOs Against Cancer
- Business Roundtable — Active member
- SMU Commencement Speaker — Featured keynote speaker at Southern Methodist University’s commencement
Tyler was honored by the American Cancer Society with its St. George National Award, recognizing his significant contributions to cancer research and care. He is a passionate advocate for improving healthcare access and has spoken publicly about McKesson’s role in critical national health initiatives, including COVID-19 vaccine distribution.
(Related: Pfizer CEO Email & Net Worth)
About McKesson Corporation
McKesson Corporation is an American healthcare services and pharmaceutical distribution company headquartered in Irving, Texas. Founded in 1833 by John McKesson and Charles Olcott in New York City, it is one of the oldest continuously operating companies in America at nearly 200 years old. McKesson distributes approximately one-third of all pharmaceuticals consumed in North America.
Frequently Asked Questions (FAQ)
Who is the current CEO of McKesson?
Brian S. Tyler has been CEO of McKesson Corporation since April 1, 2019, succeeding John Hammergren. Tyler holds a Ph.D. in Economics from the University of Chicago and spent more than 25 years at McKesson before becoming CEO.
What is Brian Tyler’s net worth in 2026?
Brian Tyler’s net worth is estimated at $50-100 million as of 2026, based on cumulative compensation, stock holdings, and equity awards. His direct McKesson stock holdings are worth approximately $3.59 million.
What is McKesson CEO’s salary?
Brian Tyler’s total compensation for fiscal year 2025 was approximately $20.16 million, including a $1.54 million base salary, $3.67 million annual bonus, $14.5 million in stock awards, and $450,000 in other compensation. Over 92% of his pay is performance-based.
What is McKesson CEO’s email address?
McKesson CEO Brian Tyler’s email address is [email protected]. McKesson uses the [email protected] format. The corporate headquarters is at 6555 State Hwy 161, Irving, TX 75039, phone (972) 446-4800.
How big is McKesson?
McKesson is one of the largest companies in the world by revenue ($359.1 billion in FY2025), consistently ranking in the Fortune 500 top 10. It has a market capitalization exceeding $121 billion and distributes approximately one-third of all pharmaceuticals in North America.
What is Brian Tyler’s educational background?
Brian Tyler earned a B.A. in Economics with high honors from the University of California, Santa Cruz in 1989, and both an M.A. and Ph.D. in Economics from the University of Chicago in 1994. He studied under a National Science Foundation grant, specializing in industrial organization, labor economics, and public finance.
Article last updated:January 2026March 4, 2026
Disclaimer: All information presented in this article has been compiled from publicly available sources, including SEC filings, official company press releases, McKesson proxy statements, and reputable news outlets. Net worth figures are estimates based on disclosed stock holdings and may not reflect the complete financial picture. This content is provided for informational purposes only and does not constitute financial or investment advice.